Immunogen, 4.5% 1jul2021, USD (Conv.) (FIGI BBG00D35RCY3, WKN A19MQG)
国内債券, 転換社債, Senior Unsecured
国内債券, 転換社債, Senior Unsecured
|
ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
175 910
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |